Back to results
US 2022/0088061 A1Published application
Cosmetic/dermatological composition
AssigneesDenis BARRITAULT, Organes, Tissus: Régénération, Réparation, Remplacement
InventorDenis BARRITAULT
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical or dermatological composition and to its use as a medicament. The present invention also relates to a cosmetic or dermatological composition, as well as to a care kit including the composition of the invention. The present invention finds an application in particular in the cosmetic, pharmaceutical and veterinary fields.
Claims21
Pharmaceutical or dermatological composition for use as a medicament, said composition comprising
- a biocompatible polymer of the general formula (I) below
- AaXxYy (I)
- in which:
- A represents a monomer,
- X represents an R1COOR2 or —R9(C═O)R10 group,
- Y represents an O or N-sulfonate group complying with one of the following formulae:
- —R3OSO3R4, —R5NSO3R6, R7SO3R8 in which:
- R1, R3, R5 and R9 independently represent an aliphatic hydrocarbon chain, optionally branched and/or unsaturated, and which optionally contains one or more aromatic cycles with the exception of benzylamine and benzylamine sulfonate, R2, R4, R6 and R8 independently represent a hydrogen atom or a cation,
- R7 and R10 independently represent a bond, an aliphatic hydrocarbon chain, optionally branched and/or unsaturated,
- a represents the number of monomers,
- x represents the rate of substitution of the monomers A by the groups X, y represents the rate of substitution of the monomers A by the groups Y, and
- hyaluronic acid.
9 more elements
Cosmetic non-therapeutic or dermatological use of a composition comprising:
- a biocompatible polymer of the general formula (I) below
- AaXxYy (I)
- in which:
- A represents a monomer,
- X represents an R1COOR2 or —R9(C═O)R10 group, Y represents an O or N-sulfonate group complying with one of the following formulae:
- —R3OSO3R4, —R5NSO3R6, R7SO3R8 in which:
- R1, R3, R5 and R9 independently represent an aliphatic hydrocarbon chain, optionally branched and/or unsaturated, and which optionally contains one or more aromatic cycles with the exception of benzylamine and benzylamine sulfonate, R2, R4, R6 and R8 independently represent a hydrogen atom or a cation,
- R7 and R10 independently represent a bond, an aliphatic hydrocarbon chain, optionally branched and/or unsaturated,
- a represents the number of monomers,
- x represents the rate of substitution of the monomers A by the groups X, y represents the rate of substitution of the monomers A by the groups Y, and
- hyaluronic acid.
8 more elements
Use of a pharmaceutical composition comprising:
- i. a biocompatible polymer of the general formula (I) below
- AaXxYy (I)
- in which:
- A represents a monomer,
- X represents an R1COOR2 group, Y represents an O or N-sulfonate group complying with one of the following formulae:
- —R3OSO3R4, —R5NSO3R6, R7SO3R8 in which:
- R1, R3, R5 and R9 independently represent an aliphatic hydrocarbon chain, optionally branched and/or unsaturated, and which optionally contains one or more aromatic cycles with the exception of benzylamine and benzylamine sulfonate, R2, R4, R6 and R8 independently represent a hydrogen atom or a cation,
- R7 and R10 independently represent a bond, an aliphatic hydrocarbon chain, optionally branched and/or unsaturated,
- a represents the number of monomers,
- x represents the rate of substitution of the monomers A by the groups X, y represents the rate of substitution of the monomers A by the groups Y, and
- ii. hyaluronic acid
- for the preparation of a medicament.
9 more elements
Cosmetic non-therapeutic use of a composition comprising:
- i. a biocompatible polymer of the general formula (I) below
- AaXxYy (I)
- in which:
- A represents a monomer,
- X represents an R1COOR2 group,
- Y represents an O or N-sulfonate group complying with one of the following formulae:
- —R3OSO3R4, —R5NSO3R6, R7SO3R8 in which:
- R1, R3, R5 and R9 independently represent an aliphatic hydrocarbon chain, optionally branched and/or unsaturated, and which optionally contains one or more aromatic cycles with the exception of benzylamine and benzylamine sulfonate, R2, R4, R6 and R8 independently represent a hydrogen atom or a cation,
- R7 and R10 independently represent a bond, an aliphatic hydrocarbon chain, optionally branched and/or unsaturated,
- a represents the number of monomers,
- x represents the rate of substitution of the monomers A by the groups X,
- y represents the rate of substitution of the monomers A by the groups Y, and
- ii. hyaluronic acid.
10 more elements
Dependencies are inferred from the claim text.